ホーム

Entacapone

Entacapone

規格

130929-57-6CAS番号
603-449-6EC番号
(E)-2-cyano-3-(3,4-dihydroxy-5-nitrophenyl)-N,N-diethylprop-2-enamideIUPAC名
C14H15N3O5化学式
305.29 g/mol分子量
ENTACAPONE; 130929-57-6; Comtan; Comtess; Entacapona; Entacaponum; OR-611; (E)-Entacapone; Entacapone teva; Entacapone orion; DTXSID5046439; (2E)-2-cyano-3-(3,4-dihydroxy-5-nitrophenyl)-N,N-diethylprop-2-enamide; 2-Propenamide, 2-cyano-3-(3,4-dihydroxy-5-nitrophenyl)-N,N-diethyl-, (2E)-; (E)-alpha-Cyano-N,N-diethyl-3,4-dihydroxy-5-nitrocinnamamide; (E)-2-cyano-3-(3,4-dihydroxy-5-nitro-phenyl)-N,N-diethyl-prop-2-enamide; 4975G9NM6T; N,N-diethyl-2-cyano-3-(3,4-dihydroxy-5-nitrophenyl) acrylamide; CHEBI:4798; DTXCID3026439; 2-Cyano-N,N-diethyl-3-(3,4-dihydroxy-5-nitrophenyl)propenamide; STALEVO COMPONENT ENTACAPONE; CORBILTA COMPONENT ENTACAPONE; LEVODOPA/CARBIDOPA/ENTACAPONE ORION COMPONENT ENTACAPONE; RefChem:56991; N04BX02; (E)-2-cyano-3-(3,4-dihydroxy-5-nitrophenyl)-N,N-diethylacrylamide; 116314-67-1; MFCD00866580; (2E)-2-Cyano-3-(3,4-dihydroxy-5-nitrophenyl)-N,N-diethyl-2-propenamide; (E)-2-cyano-3-(3,4-dihydroxy-5-nitrophenyl)-N,N-diethylprop-2-enamide; 2-Propenamide, 2-cyano-3-(3,4-dihydroxy-5-nitrophenyl)-N,N-diethyl-; CHEMBL953; Entacaponum [INN-Latin]; Entacapona [INN-Spanish]; NCGC00164555-01; Entacom; OR 611; (~{E})-2-cyano-~{N},~{N}-diethyl-3-[3-nitro-4,5-bis(oxidanyl)phenyl]prop-2-enamide; Comtan (TN); CAS-130929-57-6; SR-05000001452; UNII-4975G9NM6T; Entacapone?; Entacapone CRS; COM-998; Entacapone [USAN:USP:INN:BAN]; Entacapone (Standard); ENTACAPONE [MI]; ENTACAPONE [INN]; ENTACAPONE [JAN]; ENTACAPONE [USAN]; ENTACAPONE [VANDF]; ENTACAPONE [MART.]; ENTACAPONE [USP-RS]; ENTACAPONE [WHO-DD]; SCHEMBL34504; BIDD:GT0026; ENTACAPONE [EMA EPAR]; Entacapone (JP17/USP/INN); GTPL6647; ENTACAPONE [ORANGE BOOK]; SCHEMBL29356206; HSDB 8251; ENTACAPONE [EP MONOGRAPH]; ENTACAPONE [USP MONOGRAPH]; GLXC-01688; HMS2089O16; HMS3713B20; HMS3885K09; HMS5081C20; OR611; EX-A1130; Tox21_112184; AC-393; BDBM50108879; EBC-07837; HY-14280R; s3147; AKOS015907685; AKOS015965009; Tox21_112184_1; CCG-213064; CS-1266; DB00494; FC22678; NCGC00164555-02; NCGC00164555-03; NCGC00164555-10; HY-14280; SY024802; E0961; E5575; NS00006886; SW199035-2; C07943; D00781; AB01275450-01; AB01275450_02; AB01275450_03; F794549; Q416444; SR-05000001452-1; SR-05000001452-2; SR-05000001452-3; BRD-K83636919-001-01-4; BRD-K83636919-001-03-0; BRD-K83636919-001-04-8; BRD-K83636919-001-05-5; 2-Cyano-3-(3,4-dihydroxy-5-nitrophenyl)-N,N-diethylacrylamide; (E)-N,N-diethyl-2-cyano-3-(3,4-dihydroxy-5-nitrophenyl)acrylamide; (E)-.ALPHA.-CYANO-N,N-DIETHYL-3,4-DIHYDROXY-5-NITROCINNAMAMIDE; (E)-N, N-diethyl-2-cyano-3-(3,4-dihydroxy-5-nitrophenyl)acrylamide; 686349-59-7; PD9別名